These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33948452)

  • 41. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
    Amin SA; Ghosh K; Gayen S; Jha T
    J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
    Alam S; Kamal TB; Sarker MMR; Zhou JR; Rahman SMA; Mohamed IN
    Front Pharmacol; 2021; 12():659577. PubMed ID: 34220503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease.
    Hussien MA; Abdelaziz AEM
    Netw Model Anal Health Inform Bioinform; 2020; 9(1):56. PubMed ID: 32834922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
    Mostafa A; Kandeil A; A M M Elshaier Y; Kutkat O; Moatasim Y; Rashad AA; Shehata M; Gomaa MR; Mahrous N; Mahmoud SH; GabAllah M; Abbas H; Taweel AE; Kayed AE; Kamel MN; Sayes ME; Mahmoud DB; El-Shesheny R; Kayali G; Ali MA
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33291642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors.
    Kalhotra P; Chittepu VCSR; Osorio-Revilla G; Gallardo-Velazquez T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33578831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.
    Peele KA; Kumar V; Parate S; Srirama K; Lee KW; Venkateswarulu TC
    J Pharm Sci; 2021 Jun; 110(6):2346-2354. PubMed ID: 33684397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular docking and ADMET studies of
    Adegbola PI; Semire B; Fadahunsi OS; Adegoke AE
    Virusdisease; 2021 Mar; 32(1):85-97. PubMed ID: 33869672
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Sarı S; Avci A; Koçak Aslan E
    Turk J Pharm Sci; 2021 Dec; 18(6):730-737. PubMed ID: 34978402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
    Chakraborti S; Bheemireddy S; Srinivasan N
    Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
    Biering SB; Van Dis E; Wehri E; Yamashiro LH; Nguyenla X; Dugast-Darzacq C; Graham TGW; Stroumza JR; Golovkine GR; Roberts AW; Fines DM; Spradlin JN; Ward CC; Bajaj T; Dovala D; Schulze-Gamen U; Bajaj R; Fox DM; Ott M; Murthy N; Nomura DK; Schaletzky J; Stanley SA
    ACS Infect Dis; 2021 Aug; 7(8):2337-2351. PubMed ID: 34129317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
    Wei TZ; Wang H; Wu XQ; Lu Y; Guan SH; Dong FQ; Dong CL; Zhu GL; Bao YZ; Zhang J; Wang GY; Li HY
    Chin J Integr Med; 2020 Sep; 26(9):663-669. PubMed ID: 32740825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus.
    Tietcheu Galani BR; Ayissi Owona VB; Guemmogne Temdie RJ; Metzger K; Atsama Amougou M; Djamen Chuisseu PD; Fondjo Kouam A; Ngounoue Djuidje M; Aliouat-Denis CM; Cocquerel L; Fewou Moundipa P
    In Silico Pharmacol; 2021; 9(1):35. PubMed ID: 33959472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
    Bafna K; White K; Harish B; Rosales R; Ramelot TA; Acton TB; Moreno E; Kehrer T; Miorin L; Royer CA; García-Sastre A; Krug RM; Montelione GT
    Cell Rep; 2021 May; 35(7):109133. PubMed ID: 33984267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Shabbir S; Raza MH; Arshad M; Khan MJ
    Arch Virol; 2021 Aug; 166(8):2109-2117. PubMed ID: 33950288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serine Protease Inhibitors to Treat Lung Inflammatory Diseases.
    El Amri C
    Adv Exp Med Biol; 2021; 1304():215-226. PubMed ID: 34019272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antivirals virtual screening to SARS-CoV-2 non-structural proteins.
    Nunes VS; Paschoal DFS; Costa LAS; Santos HFD
    J Biomol Struct Dyn; 2022; 40(19):8989-9003. PubMed ID: 33949279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic strategies to fight COVID-19: Which is the status artis?
    Scavone C; Mascolo A; Rafaniello C; Sportiello L; Trama U; Zoccoli A; Bernardi FF; Racagni G; Berrino L; Castaldo G; Coscioni E; Rossi F; Capuano A
    Br J Pharmacol; 2022 May; 179(10):2128-2148. PubMed ID: 33960398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the
    Al-Karmalawy AA; Dahab MA; Metwaly AM; Elhady SS; Elkaeed EB; Eissa IH; Darwish KM
    Front Chem; 2021; 9():661230. PubMed ID: 34017819
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.